68Ga-PSMA-11

You have access
Head to head comparison of ⁶⁸Ga-NGUL and ⁶⁸Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study
Minseok Suh, Hyung-Jun Im, Hyun Gee Ryoo, Keon Wook Kang, Jae Min Jeong, Sneha Kumar, SANJANA S BALLAL, Madhav P Yadav, Chandrasekhar Bal, Chang Wook Jeong, Cheol Kwak and Gi Jeong Cheon

Journal of Nuclear Medicine February 26, 2021, jnumed.120.258434; DOI: https://doi.org/10.2967/jnumed.120.258434
Open Access
⁶⁸Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha and Shaojun Zhu

Journal of Nuclear Medicine February 1, 2021, 62 (2) 149-155; DOI: https://doi.org/10.2967/jnumed.120.260455
You have access
Disparities in PET imaging for prostate cancer at a tertiary academic medical center
Matthew D. Bucknor, Daphne Y. Lichtensztajn, Tracy K. Lin, Hala T. Borno, Scarlett L. Gomez and Thomas A. Hope

Journal of Nuclear Medicine September 25, 2020, jnumed.120.251751; DOI: https://doi.org/10.2967/jnumed.120.251751
You have access
Intraindividual Comparison of ¹⁸F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer
Felix Dietlein, Carsten Kobe, Melanie Hohberg, Boris D. Zlatopolskiy, Philipp Krapf, Heike Endepols, Philipp Täger, Jochen Hammes, Axel Heidenreich, Thorsten Persigehl, Bernd Neumaier, Alexander Drzezga and Markus Dietlein

Journal of Nuclear Medicine May 1, 2020, 61 (5) 729-734; DOI: https://doi.org/10.2967/jnumed.119.234898
You have access
Head-to-Head Comparison of ⁶⁸Ga-PSMA-11 with ¹⁸F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
Jonathan Kuten, Ibrahim Fahoum, Ziv Savin, Ofer Shamni, Gilad Gitstein, Dov Hershkovitz, Nicola J. Mabjeesh, Ofer Yossepowitch, Eyal Mishani and Einat Even-Sapir

Journal of Nuclear Medicine April 1, 2020, 61 (4) 527-532; DOI: https://doi.org/10.2967/jnumed.119.234187
You have access
Detection Rate and Localization of Prostate Cancer Recurrence Using ⁶⁸Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL
Benedikt Kranzbühler, Julian Müller, Anton S. Becker, Helena I. Garcia Schüler, Urs Muehlematter, Christian D. Fankhauser, Sarah Kedzia, Matthias Guckenberger, Philipp A. Kaufmann, Daniel Eberli and Irene A. Burger

Journal of Nuclear Medicine February 1, 2020, 61 (2) 194-201; DOI: https://doi.org/10.2967/jnumed.118.225276
You have access
First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for ⁶⁸Ga-PSMA-11 in Salivary Glands
Niels J. Rupp, Christoph A. Umbricht, Daniele A. Pizzuto, Daniela Lenggenhager, Antonia Töpfer, Julian Müller, Urs J. Muehlematter, Daniela A. Ferraro, Michael Messerli, Grégoire B. Morand, Gerhard F. Huber, Daniel Eberli, Roger Schibli, Cristina Müller and Irene A. Burger

Journal of Nuclear Medicine September 1, 2019, 60 (9) 1270-1276; DOI: https://doi.org/10.2967/jnumed.118.222307
Open Access
Monosodium Glutamate Reduces ⁶⁸Ga-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model
Etienne Rousseau, Joseph Lau, Hsiou-Ting Kuo, Zhengxing Zhang, Helen Merkens, Navjit Hundal-Jabal, Nadine Colpo, Kuo-Shyan Lin and François Bénard

Journal of Nuclear Medicine December 1, 2018, 59 (12) 1865-1868; DOI: https://doi.org/10.2967/jnumed.118.215350

Main menu

User menu

Search

68Ga-PSMA-11